Fox Run Management L.L.C. Makes New Investment in Encompass Health Co. (NYSE:EHC)

Fox Run Management L.L.C. acquired a new stake in Encompass Health Co. (NYSE:EHC - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 17,240 shares of the company's stock, valued at approximately $1,592,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB increased its stake in Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after purchasing an additional 137 shares in the last quarter. Avior Wealth Management LLC bought a new stake in shares of Encompass Health during the third quarter worth $40,000. CBIZ Investment Advisory Services LLC raised its holdings in shares of Encompass Health by 38.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after acquiring an additional 127 shares during the period. Tompkins Financial Corp bought a new stake in Encompass Health in the 4th quarter valued at $46,000. Finally, V Square Quantitative Management LLC boosted its stake in Encompass Health by 43.8% in the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock worth $54,000 after purchasing an additional 177 shares during the period. 97.25% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. William Blair restated an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $110.00 price target on shares of Encompass Health in a research report on Tuesday, February 11th. StockNews.com upgraded shares of Encompass Health from a "hold" rating to a "buy" rating in a report on Saturday, February 15th. KeyCorp increased their target price on shares of Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a report on Monday, February 10th. Finally, Barclays lifted their price target on shares of Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a research note on Friday, February 7th. Ten equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average target price of $107.67.

Remove Ads

Encompass Health Stock Performance

Encompass Health stock traded down $0.54 during mid-day trading on Wednesday, hitting $100.33. 503,931 shares of the company's stock traded hands, compared to its average volume of 633,615. Encompass Health Co. has a fifty-two week low of $77.09 and a fifty-two week high of $104.55. The stock has a market cap of $10.10 billion, a price-to-earnings ratio of 22.50, a P/E/G ratio of 2.31 and a beta of 0.92. The firm has a 50 day simple moving average of $98.42 and a two-hundred day simple moving average of $97.29. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, beating analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. On average, research analysts expect that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be issued a dividend of $0.17 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.68%. Encompass Health's dividend payout ratio is presently 15.25%.

Insider Activity

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the transaction, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at $6,798,129.56. The trade was a 6.79 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.10% of the stock is owned by company insiders.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.